aid: arrakis
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/arrakis.png
name: Arrakis
description: 'Arrakis Therapeutics is a biopharmaceutical company pioneering
  RNA-targeted small molecules (rSMs) as a new class of genetic medicines. Its rSM
  platform enables orally available small molecules to bind RNA and modulate previously
  undruggable biological pathways, with an industrialized discovery toolkit spanning
  multiple modalities. The lead proprietary program targets Type 1 Myotonic Dystrophy
  (DM1) at the root cause of the disease, alongside a pipeline of proprietary and
  partnered programs. A GV (Google Ventures) portfolio company in the life-sciences
  sector, Arrakis was added to the API Evangelist network as a company profile; it
  publishes a corporate and scientific website but no public developer API surface.'
url: https://raw.githubusercontent.com/api-evangelist/arrakis/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- gv
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-18'
tags:
- Company
- Life Sciences
- Biotechnology
- Pharmaceuticals
- RNA
- Drug Discovery
- Genetic Medicine
- Therapeutics
apis: []
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
common:
- type: DomainSecurity
  url: security/arrakis-domain-security.yml
- type: Website
  url: https://arrakistx.com
- type: About
  url: https://arrakistx.com/about/
- type: Blog
  url: https://arrakistx.com/news/
- type: Support
  url: https://arrakistx.com/contact/
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence